ACAD
36.53
-0.45
-1.22%
AEMD
1.798
-0.152
-7.7744%
APRI
1.75
-0.02
-1.13%
ARNA
24.53
+0.22
+0.90%
ATEC
2.117
-0.103
-4.6532%
CNAT
5.6
-0.09
-1.58%
CRXM
0.163
0.00
0.00%
CYTX
0.346
+0.006
+1.765%
DXCM
69.46
+0.2
+0.29%
GNMK
9.4
-0.25
-2.59%
HALO
16.42
-0.3
-1.79%
ILMN
204.95
-4.45
-2.13%
INNV
0.096
-0.003
-3.3266%
INO
6.07
+0.07
+1.17%
ISCO
1.53
-0.01
-0.65%
ISIS
57.56
0.00
0.00%
LGND
136.18
+1.03
+0.76%
LPTN
2.93
-2.93
-100.00%
MBVX
0.71
+0.03
+4.4124%
MEIP
2.69
0.00
0.00%
MNOV
5.47
-0.1
-1.80%
MRTX
10.55
-0.25
-2.31%
MSTX
0.13
-0.01
-5.28%
NBIX
56.34
-0.35
-0.62%
NUVA
53.515
-4.285
-7.413%
ONCS
0.99
0.00
-0.50%
ONVO
2.025
+0.035
+1.759%
OREX
2.33
-0.01
-0.43%
OTIC
3.25
-0.15
-4.41%
QDEL
43.55
+2.64
+6.45%
RCPT
231.96
0.00
0.00%
RGLS
1.32
-0.01
-0.75%
RMD
79.45
-0.08
-0.10%
SCIE
0
0.00
0.00%
SPHS
2.334
+0.012
+0.5254%
SRNE
1.75
-0.1
-5.41%
TROV
0.67
-0.03
-4.29%
VICL
2.4
-0.05
-2.04%
VOLC
18
0.00
0.00%
ZGNX
14.55
+0.3
+2.11%
ACAD
36.53
-0.45
-1.22%
AEMD
1.798
-0.152
-7.7744%
APRI
1.75
-0.02
-1.13%
ARNA
24.53
+0.22
+0.90%
ATEC
2.117
-0.103
-4.6532%
CNAT
5.6
-0.09
-1.58%
CRXM
0.163
0.00
0.00%
CYTX
0.346
+0.006
+1.765%
DXCM
69.46
+0.2
+0.29%
GNMK
9.4
-0.25
-2.59%
HALO
16.42
-0.3
-1.79%
ILMN
204.95
-4.45
-2.13%
INNV
0.096
-0.003
-3.3266%
INO
6.07
+0.07
+1.17%
ISCO
1.53
-0.01
-0.65%
ISIS
57.56
0.00
0.00%
LGND
136.18
+1.03
+0.76%
LPTN
2.93
-2.93
-100.00%
MBVX
0.71
+0.03
+4.4124%
MEIP
2.69
0.00
0.00%
MNOV
5.47
-0.1
-1.80%
MRTX
10.55
-0.25
-2.31%
MSTX
0.13
-0.01
-5.28%
NBIX
56.34
-0.35
-0.62%
NUVA
53.515
-4.285
-7.413%
ONCS
0.99
0.00
-0.50%
ONVO
2.025
+0.035
+1.759%
OREX
2.33
-0.01
-0.43%
OTIC
3.25
-0.15
-4.41%
QDEL
43.55
+2.64
+6.45%
RCPT
231.96
0.00
0.00%
RGLS
1.32
-0.01
-0.75%
RMD
79.45
-0.08
-0.10%
SCIE
0
0.00
0.00%
SPHS
2.334
+0.012
+0.5254%
SRNE
1.75
-0.1
-5.41%
TROV
0.67
-0.03
-4.29%
VICL
2.4
-0.05
-2.04%
VOLC
18
0.00
0.00%
ZGNX
14.55
+0.3
+2.11%
Home » Archive by Category

Xconomy

On CAR-T’s Edge, Seattle Researchers Plot to Bypass Novartis Therapy

September 19, 2017 – 2:45 am

It’s not a stretch to say that Greta Oberhofer is alive thanks to the genetically modified cell therapy called CAR-T. At three and a half months old, she was diagnosed with acute lymphoblastic…

[[Click headline to continue reading.]]

Akili, Emulate, Ginkgo & More: The Innovation at the Intersection Award Finalists

September 18, 2017 – 4:00 am

Research that happens at the intersection of different fields can lead to new innovations that tackle pressing problems in the life sciences. This year’s finalists in the Innovation at the…

[[Click headline to continue reading.]]

Dealmaker, Thought Leader & More: The X of the Year Xconomy Award Finalists

September 15, 2017 – 4:00 am

Given the size and diversity of the life sciences community in the Boston area, we at Xconomy knew that many candidates would be so unique that they wouldn’t fit neatly into a category. So we gave…

[[Click headline to continue reading.]]

Bio Roundup: Phase 3 Fails, Shkreli Jailed, Moderna Flip-Flops & More

September 15, 2017 – 2:45 am

It was a week of realignments. President Trump, who used to be known as “The Donald” but now goes by “Amnesty Don,” kept up the parlay-voo with his new friends Chuck and…

[[Click headline to continue reading.]]

Going Big or Against the Tide: Meet the Big Idea & Contrarian Award Finalists

September 14, 2017 – 4:00 am

[Corrected, 1:25pm ET, see below] All innovation and companies start off as an idea. Some will gain more traction than others over time, but we at Xconomy think that big ideas—and the people…

[[Click headline to continue reading.]]

Halozyme Inks $105M Bristol-Myers Partnership, Expands Roche Deal

September 14, 2017 – 2:55 am

Halozyme Therapeutics has turned a method of delivering a drug more conveniently into partnerships with several large pharmaceutical companies that want to see their infusible drugs delivered via…

[[Click headline to continue reading.]]

Xconomy Award Finalists in the Eye of the National Drug Price Debate

September 13, 2017 – 4:00 am

[Corrected 12:20pm ET; see below.] The national debate over the high cost of healthcare, with prescription drugs at the center, resonates from the chambers of Congress to every American’s…

[[Click headline to continue reading.]]

The Winners of the Xconomy Lifetime Achievement Award Are…

September 12, 2017 – 9:53 am

The editors at Xconomy have been working hard the last few weeks putting together the program for the Xconomy Awards Gala. We are really excited to announce the two winners of the Xconomy Lifetime…

[[Click headline to continue reading.]]

Bio Roundup: RNAi Drama, Immunotherapy Data, Lasker Winners & More

September 8, 2017 – 3:48 am

The summer doldrums are over. Biotech news came at a breakneck pace this week both before and after Labor Day, starting with the surprise resignation of Novartis’s top executive just days after the…

[[Click headline to continue reading.]]

Levin, Holtzman, 183 Other Bio Leaders Urge White House to Preserve DACA

September 7, 2017 – 12:00 pm

Biotech CEOs Jeremy Levin and Steve Holtzman are continuing their recent push to spur the life sciences industry to speak out against government policies it doesn’t agree with. Levin, CEO of Ovid…

[[Click headline to continue reading.]]